Literature DB >> 10952621

Fluconazole penetration into the pancreas.

S Shrikhande1, H Friess, C Issenegger, M E Martignoni, H Yong, B Gloor, R Yeates, J Kleeff, M W Büchler.   

Abstract

Because of antibiotic prophylaxis for necrotizing pancreatitis, the frequency of fungal superinfection in patients with pancreatic necrosis is increasing. In this study we analyzed the penetration of fluconazole into the human pancreas and in experimental acute pancreatitis. In human pancreatic tissues, the mean fluconazole concentration was 8.19 +/- 3.38 microg/g (96% of the corresponding concentration in serum). In experimental edematous and necrotizing pancreatitis, 88 and 91% of the serum fluconazole concentration was found in the pancreas. These data show that fluconazole penetration into the pancreas is sufficient to prevent and/or treat fungal contamination in patients with pancreatic necrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952621      PMCID: PMC90111          DOI: 10.1128/AAC.44.9.2569-2571.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat.

Authors:  J Faergemann; H Laufen
Journal:  Clin Exp Dermatol       Date:  1993-03       Impact factor: 3.470

2.  Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.

Authors:  T E Rogers; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.

Authors:  P Pederzoli; C Bassi; S Vesentini; A Campedelli
Journal:  Surg Gynecol Obstet       Date:  1993-05

4.  Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography.

Authors:  A J Fischman; N M Alpert; E Livni; S Ray; I Sinclair; R J Callahan; J A Correia; D Webb; H W Strauss; R H Rubin
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

5.  Bacterial contamination of pancreatic necrosis. A prospective clinical study.

Authors:  H G Beger; R Bittner; S Block; M Büchler
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

6.  The penetration of antibiotics into human pancreas.

Authors:  M Büchler; P Malfertheiner; H Friess; R Bittner; E Vanek; P Schlegel; H G Beger
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

7.  Human pancreatic tissue concentration of bactericidal antibiotics.

Authors:  M Büchler; P Malfertheiner; H Friess; R Isenmann; E Vanek; H Grimm; P Schlegel; T Friess; H G Beger
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

Review 8.  Candida in pancreatic infection: a clinical experience.

Authors:  T Aloia; J Solomkin; A S Fink; M S Nussbaum; S Bjornson; R H Bell; L Sewak; D W McFadden
Journal:  Am Surg       Date:  1994-10       Impact factor: 0.688

9.  Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.

Authors:  C E Hughes; R L Bennett; I C Tuna; W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 10.  Surgical management of necrotizing pancreatitis.

Authors:  H G Beger
Journal:  Surg Clin North Am       Date:  1989-06       Impact factor: 2.741

View more
  8 in total

Review 1.  Optimising outcomes in acute pancreatitis.

Authors:  I D Norton; J E Clain
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

3.  Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration.

Authors:  Kazuaki Yagasaki; Satoshi Gando; Naoyuki Matsuda; Takashi Kameue; Toshiteru Ishitani; Takeshi Hirano; Ken Iseki
Journal:  Intensive Care Med       Date:  2003-09-13       Impact factor: 17.440

4.  Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study.

Authors:  Yue-Ming He; Xin-Sheng Lv; Zhong-Li Ai; Zhi-Su Liu; Qun Qian; Quan Sun; Ji-Wei Chen; Dao-Xiong Lei; Cong-Qing Jiang; Yu-Fong Yuan
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 5.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 6.  Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics.

Authors:  Philippe Eggimann; Saurabh Jamdar; Ajith K Siriwardena
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Pancreatic candidiasis in a cat.

Authors:  Kelsey Renner; Sarah Hill; Alex Grinberg; Amy Weeden
Journal:  JFMS Open Rep       Date:  2021-10-20

8.  JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis.

Authors:  Kazunori Takeda; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Miho Sekimoto; Masahiko Hirota; Yasutoshi Kimura; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.